期刊
JOURNAL OF NATURAL PRODUCTS
卷 72, 期 8, 页码 1465-1470出版社
AMER CHEMICAL SOC
DOI: 10.1021/np9002004
关键词
-
资金
- Korea Food and Drug Administration [08182, 257]
- Oriental Herbal Medicines
- Ministry of Trade, Industry & Energy (MOTIE), Republic of Korea [257] Funding Source: Korea Institute of Science & Technology Information (KISTI), National Science & Technology Information Service (NTIS)
The methanol extract of Moutan cortex (Paeonia suffruticosa) afforded two new compounds, 8-O-benzoylpaeonidanin (1) and 5-hydroxy-3S-hydroxymethyl-6-methyl-2,3-dihydrobenzofuran (2), in addition to 4-O-butylpaeoniflorin (3) as an artifact of the separation, seven monoterpene glycosides (4-10), two monoterpenes (11, 12), four acetophenones (13-16), and two triterpenes (17, 18). The structures of the compounds were determined by spectroscopic methods, and the compounds were evaluated for inhibitory effects against rat lens aldose reductase (RLAR) and advanced glycation end-product (AGEs) formation. Compounds 17 and 18 showed the most potent inhibitory activity against RLAR, with IC50 values of 11.4 and 28.8 mu M, respectively. Compounds 3 and 6 also inhibited RLAR with IC50 values of 36.2 and 44.6 mu M, respectively. The positive control, 3,3-tetramethyleneglutamic acid, had an IC50 value of 31.8 mu M. Compounds 3 and 6 inhibited AGE formation with IC50 values of 10.8 and 11.3 mu M, respectively. Compound 2 had an IC50 value of 177.0 mu M, whereas the positive control, aminoguanidine, had an IC50 value of 1026.8 mu M.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据